These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33708909)

  • 1. Urinary soluble CD90 predicts renal prognosis in patients with diabetic kidney disease.
    Wu L; Chang DY; Zhang LX; Chen M; Zhao MH
    Ann Transl Med; 2021 Feb; 9(4):282. PubMed ID: 33708909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
    Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.
    Lee YH; Kim KP; Park SH; Kim DJ; Kim YG; Moon JY; Jung SW; Kim JS; Jeong KH; Lee SY; Yang DH; Lim SJ; Woo JT; Rhee SY; Chon S; Choi HY; Park HC; Jo YI; Yi JH; Han SW; Lee SH
    Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31598726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of α1-MG and URBP in early diabetic renal impairment.
    Zhou Y; Zhang Y; Chen J; Wang T; Li H; Wu F; Shang J; Zhao Z
    Front Physiol; 2023; 14():1173982. PubMed ID: 37929213
    [No Abstract]   [Full Text] [Related]  

  • 6. Glutathione Peroxidase 4 Is a Predictor of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
    Wang YH; Chang DY; Zhao MH; Chen M
    Oxid Med Cell Longev; 2022; 2022():2948248. PubMed ID: 36275902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified arteriosclerosis score predicts the outcomes of diabetic kidney disease.
    Zhang Y; Jiang Q; Xie J; Qi C; Li S; Wang Y; Him YH; Chen Z; Zhang S; Li Q; Zhu Y; Li R; Liang X; Bai X; Wang W
    BMC Nephrol; 2021 Aug; 22(1):281. PubMed ID: 34407751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal and Urinary Glycogen Synthase Kinase-3 Beta Levels in Diabetic and Nondiabetic Chronic Kidney Disease.
    Zeng L; Ng JK; Fung WW; Chan GC; Chow KM; Szeto CC
    Kidney Blood Press Res; 2023; 48(1):241-248. PubMed ID: 36940673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic performance of renal compartment volume and the apparent diffusion coefficient obtained from magnetic resonance imaging in mild, moderate and severe diabetic kidney disease.
    Zhao K; Li S; Liu Y; Li Q; Lin H; Wu Z; Seeliger E; Niendorf T; Liu Z; Wang W
    Quant Imaging Med Surg; 2023 Jun; 13(6):3973-3987. PubMed ID: 37284101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary matrix metalloproteinase activity in diabetic kidney disease: a potential marker of disease progression.
    Altemtam N; Nahas ME; Johnson T
    Nephron Extra; 2012 Jan; 2(1):219-32. PubMed ID: 22949917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Diabetic Kidney Disease with Different Subtypes in Hospitalized Patients with Diabetes and Correlation Between eGFR and LncRNA XIST Expression in PBMCs.
    Lin Y; Wu P; Guo L; Feng Q; Wang L; Lin X; Yang C; Liu N; Wen C; Li X; Ma X; Xue Y; Guan M
    Diabetes Ther; 2023 Sep; 14(9):1549-1561. PubMed ID: 37422842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and Urinary Progranulin in Diabetic Kidney Disease.
    Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
    PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.